167 related articles for article (PubMed ID: 6165218)
1. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
Schwarz HP; Aiginger P; Kuzmits R
Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitor and gastric cancer.
Tsumoto S; Oyabu H; Kageyama T
Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
[No Abstract] [Full Text] [Related]
3. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
[No Abstract] [Full Text] [Related]
4. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
Oguri T; Hosoi A
Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
[No Abstract] [Full Text] [Related]
5. Tissue plasminogen activator blood level in preterm infants.
Cohen AM; Creter D; Dulitzky F; Kadouri A; Sirota L
Isr J Med Sci; 1993 Apr; 29(4):204-7. PubMed ID: 7684032
[No Abstract] [Full Text] [Related]
6. The study of local fibrinolysis in abortion.
Ikeuchi M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
[No Abstract] [Full Text] [Related]
8. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
Mikami A; Kohno M
Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
[TBL] [Abstract][Full Text] [Related]
9. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
Matsuda T
Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
[No Abstract] [Full Text] [Related]
10. Human plasma proteinase inhibitors.
Travis J; Salvesen GS
Annu Rev Biochem; 1983; 52():655-709. PubMed ID: 6193754
[No Abstract] [Full Text] [Related]
11. Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.
Reitz M; Witzke G; Egbring R; Gutjahr P
Klin Wochenschr; 1984 Dec; 62(24):1165-9. PubMed ID: 6085131
[TBL] [Abstract][Full Text] [Related]
12. Blood levels of proteinase inhibitors in pregnancy.
Walker JE; Campbell DM; Ogston D
Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
[TBL] [Abstract][Full Text] [Related]
13. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
Noda Y; Nakamura M; Sasaki M; Kosugi T
Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
Harpel PC; Rosenberg RD
Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
[No Abstract] [Full Text] [Related]
17. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Travis J; Salvesen G
Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
[TBL] [Abstract][Full Text] [Related]
18. [Clinical problems of the natural coagulation and fibrinolysis inhibitors--introduction (author's transl)].
Aoki N
Rinsho Ketsueki; 1978 Jul; 19(7):917-9. PubMed ID: 81326
[No Abstract] [Full Text] [Related]
19. [Fibrinolysis and complement-system profiles during aorto-femoral bypass implantation].
Wüst HJ; Fiedler HW; Trobisch H; Richter O
Anaesthesist; 1982 Oct; 31(10):564-74. PubMed ID: 6185014
[TBL] [Abstract][Full Text] [Related]
20. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
Rao AK; Schmaier AH; Colman RW
Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
